Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996
Central Nervous System Germinomas, A Review
Arch Neurol 48:652-657, Horowitz,M.B.&Hall,W.A., 1991
MR Imaging of Pineal Tumors
AJR 155:143-151, Tien,R.D.,et al, 1990
CSF Evaluation in Primary CNS Lymphoma Patients by PCR of the CDR III IgH Genes
Neurol 58:390-396,339, Gleissner,B.,et al, 2002
The Value of Interphase Cytogenetics in Cytology for the Diagnosis of Leptomeningeal Metastases
Neurol 51:906-908, Van Oostengrugge,R.J.,et al, 1998
CSF Carcinoembryonic Antigen in Meningeal Carcinomatosis From Breast Cancer
JAMA 244:1601-1603, Yap,B-S.,et al, 1980
Cerebrospinal Fluid Biochemical Markers of Central Nervous System Metastases
Ann Neurol 8:597-604, Schold,S.C.,et al, 1980
Cytologically Negative Carcinomatous Meningitis:Usefulness of CSF Biochemical Markers
Neurol 50:1173-1175, Chamberlain,M.C., 1998
Eval of CSF EBV-DNA and IL-10 as Markers for In Vivo Dx of AIDS-Related Primary CNS Lymphoma
British J Haematology 90:844-849, DeLuca,A.,et al, 1995
Epstein-Barr Virus DNA in Cerebrospinal Fluid from Patients with AIDS-Related Primary Lymphoma of the Central Nervous System
Lancet 342:398-401, Cinque,P.,et al, 1993
Glucosephosphate Isomerase as a CSF Marker for Leptomeningeal Metastasis
Neurol 41:395-398, Newton,H.B.,et al, 1991
Neoplastic Meningitis in Malignant Melanoma:Diagnosis with Monoclonal Antibodies
JNNP 52:881-886, Moseley,R.P.,et al, 1989
Use of Monoclonal Antibody Panel to Identify Malignant Cells in Cerebrospinal Fluid
Lancet 1:1095-1098, Coakham,H.B.,et al, 1984
Cerebrospinal Fluid:A Selective Review
Ann Neurol 11; 1-101982., Cutler,R.W.P.,et al, 1982
CSF B-Glucoronidase Assay in the Diagnosis of Neoplastic Meningitis
Arch Neurol 37:684-687, Shuttleworth,E.,et al, 1980